Hanseeuw, Bernard J.
Jonas, Victoria
Jackson, Jonathan
Betensky, Rebecca A.
Rentz, Dorene M.
Johnson, Keith A.
Sperling, Reisa A.
Donovan, Nancy J.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R21AG054953, K24 AG035007, P01 AGO36694, R01 AG037497)
Fonds De La Recherche Scientifique - FNRS (SPD28094292)
Article History
Received: 12 December 2017
Revised: 30 May 2018
Accepted: 20 June 2018
First Online: 16 August 2018
Change Date: 8 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41380-018-0323-y
Compliance with ethical standards
:
: BJH has served as a paid consultant for GE Healthcare. VJ, JJ, and RAB have no disclosures. DMR has served as a paid consultant for Eli Lilly, Janssen, and Biogen, and sits on the Scientific Advisory Board for Neurotrack. KAJ has served as paid consultant for Biogen, Janssen, Piramal, Novartis, Genetech, Roche, Lundbeck, Eli Lilly, Genzyme, AZtherapies, Abbvie, and Merck. RAS has served as a paid consultant for Abbvie, Biogen, Bracket, Genentech, Lundbeck, Roche, and Sanofi. She has served as a co-investigator for Avid, Eli Lilly, and Janssen. She has spoken at symposia sponsored by Eli Lilly, Biogen, and Janssen. NJD has received salary support from Eisai and Eli Lilly. She has served as a paid consultant to Avanir Pharmaceuticals. Her spouse is employed by Alkermes. None of these relationships are related to the content of the manuscript.